IRAG
GRDN

Investment Research & Advisory Group’s Guardian Pharmacy Services GRDN Stock Holding History

Investment Research & Advisory Group’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.8K Hold
1,666
– – 0.02% 117
2026
Q1 		$62.7K Hold
1,666
– – 0.02% 114
2025
Q4 		$50.1K Hold
1,666
– – 0.02% 119
2025
Q3 		$43.7K Hold
1,666
– – 0.01% 120
2025
Q2 		$35.5K Hold
1,666
– – 0.01% 121
2025
Q1 		$35.4K Hold
1,666
– – 0.01% 124
2024
Q4 		$33.8K Buy
+1,666
New +$34.4K 0.01% 116

Other funds holding GRDN

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KPP
Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
PFM
Premier Fund Managers Guildford, United Kingdom $1.1B AUM 14.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Investment Research & Advisory Group's GRDN Position: Q2 2026 in Review

Investment Research & Advisory Group held its Guardian Pharmacy Services (GRDN) position steady in Q2 2026 at 1,666 shares worth $69.8K. The position accounts for 0.02% of the portfolio, ranked #117.

Investment Research & Advisory Group first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. 17 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Investment Research & Advisory Group held 1,666 shares of Guardian Pharmacy Services worth $69.8K as of Q2 2026.
  • Investment Research & Advisory Group left its Guardian Pharmacy Services share count unchanged in Q2 2026.
  • Guardian Pharmacy Services made up 0.02% of Investment Research & Advisory Group's portfolio in Q2 2026, its #117 holding.
  • Investment Research & Advisory Group first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • 17 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Investment Research & Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.